Researchers have found that proteotoxic stress response drives t cell exhaustion, which may impact the effectiveness of immunotherapy in chronic infections and cancer. The discovery may help explain why cancer immunotherapy sometimes fails, with some studies suggesting that protein quality control collapse or tumor stress play a role in this process. The exact mechanisms and potential solutions, including the possible use of antioxidants, are being explored in various studies.